Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 13;23(1):65.
doi: 10.1186/s12969-025-01087-2.

Role of long non-coding RNAs and circular RNAs in kawasaki disease: a systematic review

Affiliations

Role of long non-coding RNAs and circular RNAs in kawasaki disease: a systematic review

Zahra Amirsardari et al. Pediatr Rheumatol Online J. .

Abstract

Objective: Previous research has identified the significant roles of non-coding RNAs (ncRNAs) in Kawasaki disease (KD). This systematic review aims to elucidate the involvement and significance of long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in the pathogenesis and progression of KD.

Study design: A systematic search was conducted across four databases (PubMed, Embase, Scopus, and Web of Science) up to June 19, 2023, without year restrictions. The risk of bias was assessed using the Newcastle-Ottawa Scale.

Results: This review included 9 studies encompassing a total of 1894 individuals diagnosed with KD. Seven lncRNAs-Slco4a1, SOCS2-AS1, SRA, HCG22, MHRT, XLOC_006277, and HSD11B1-AS1-were found to be associated with KD, including polymorphisms such as lncRNA rs1814343 C > T and AC008392.1 rs7248320. Additionally, four circRNAs-circRNA-3302, circ7632, circANRIL, and hsa_circ_0123996-were associated with KD.

Conclusions: Both linear lncRNAs and circRNAs play critical roles in unraveling the mechanisms underlying KD, contributing to biomarker identification and potential therapeutic advances.

Keywords: Circular RNA; Kawasaki disease; Long non-coding RNA; Non-coding RNA; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: All the authors agree with the publication of this systematic review. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flowchart

Similar articles

References

    1. Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016;67(14):1738–49. - PubMed
    1. Amirsardari Z, Amirsardari F, Kohansal E, Jolfay AG, Dehaki MG, Ziaee V. Exploring the association between serum vitamin D levels and the development of coronary artery lesions in Kawasaki disease-a systematic review. Pediatr Rheumatol. 2024;22(1):71. - PMC - PubMed
    1. Burns JC. The etiologies of Kawasaki disease. J Clin Investig. 2024;134(5). - PMC - PubMed
    1. Zhong X, Jia X, Wang H, Chen G, Li H, Li P, et al. Diagnostic significance of noncoding RNAs in Kawasaki disease: A systematic review and meta-analysis. Front Pead. 2023;10:1071434. - PMC - PubMed
    1. Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen L-L, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430–47. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources